These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells. Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200 [TBL] [Abstract][Full Text] [Related]
23. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639 [TBL] [Abstract][Full Text] [Related]
24. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory. Hao S; Yuan J; Xiang J J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150 [TBL] [Abstract][Full Text] [Related]
25. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma. Cao DY; Yang JY; Yue SQ; Tao KS; Song ZS; Wang DS; Yang YL; Dou KF Cell Immunol; 2009; 259(1):13-20. PubMed ID: 19545862 [TBL] [Abstract][Full Text] [Related]
32. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique. Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268 [TBL] [Abstract][Full Text] [Related]
33. Anti-tumor effects of dendritic and tumor cell fusions are not dependent on expression of MHC class I and II by dendritic cells. Takagi Y; Kikuchi T; Niimura M; Ohno T Cancer Lett; 2004 Sep; 213(1):49-55. PubMed ID: 15312683 [TBL] [Abstract][Full Text] [Related]
34. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380 [TBL] [Abstract][Full Text] [Related]
35. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs. Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753 [TBL] [Abstract][Full Text] [Related]
36. Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells. Koido S; Tanaka Y; Tajiri H; Gong J Vaccine; 2007 Mar; 25(14):2610-9. PubMed ID: 17239504 [TBL] [Abstract][Full Text] [Related]
37. Tumor cell lysates as immunogenic sources for cancer vaccine design. González FE; Gleisner A; Falcón-Beas F; Osorio F; López MN; Salazar-Onfray F Hum Vaccin Immunother; 2014; 10(11):3261-9. PubMed ID: 25625929 [TBL] [Abstract][Full Text] [Related]
38. Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation. Koido S; Ohana M; Liu C; Nikrui N; Durfee J; Lerner A; Gong J Clin Immunol; 2004 Dec; 113(3):261-9. PubMed ID: 15507391 [TBL] [Abstract][Full Text] [Related]
39. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses. Du YC; Lin P; Zhang J; Lu YR; Ning QZ; Wang Q Tissue Antigens; 2006 May; 67(5):368-76. PubMed ID: 16671943 [TBL] [Abstract][Full Text] [Related]
40. Addition of TAT protein transduction domain and GrpE to human p53 provides soluble fusion proteins that can be transduced into dendritic cells and elicit p53-specific T-cell responses in HLA-A*0201 transgenic mice. Justesen S; Buus S; Claesson MH; Pedersen AE Immunology; 2007 Nov; 122(3):326-34. PubMed ID: 17610503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]